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Chronic health conditions are often associated with what is termed disability. Traditional 
thinking has focused on diagnosis and treatment of chronic diseases and disorders, 
with less attention to people’s functional abilities and their contextual determinants. 
Understanding all of these factors is integral to addressing the predicaments and 
needs of persons with chronic conditions. However, these complementary yet distinct 
“worldviews” reflected in what we call disease and disability perspectives often 
remain, at best, only vaguely articulated. In this paper, we explore and expand on 
these perspectives in light of conceptual advances, specifically the framework of the 
World Health Organization’s International Classification of Functioning, Disability and 
Health, and their epistemic underpinnings with reference to Wilhelm Windelband’s 
notions of nomothetic and idiographic types of knowledge. Our primary focus 
is the children with neurodisability – life-long conditions that onset early in life and 
have functional consequences that impact developmental trajectories. We critically 
review and analyze conceptual material, along with clinical and research evidence 
relevant to the experiential and clinical realities of this population, to demonstrate the 
limitations of a biomedically based diagnostic–therapeutic paradigm at the expense  
of a developmental and disability-oriented perspective. Our main aim in this paper is 
to argue for an explicit recognition of both disease and disability perspectives, and a 
more balanced and appr opriate deployment of these concepts across the continuum 
of clinical services, research, policy-making and professional and public education in 
relation to children with neurodisability; we also provide concrete recommendations to 
advance this progressive strategy. The relevance of these aims and strategies, however, 
extends beyond this particular population.
Keywords: childhood neurodisability, international Classification of Functioning, Disability and Health, human 
functioning, rehabilitation, biomedical diagnostic–therapeutics, nomothetic and idiographic knowledge
iNTRODUCTiON
Many child-onset chronic health conditions are associated with functional limitations (traditionally 
referred to as “disabilities”). For some of these conditions, the presence, or, perhaps more accurately, 
the experience of disability, is a defining characteristic. The term neurodisability refers to “a group 
of congenital or acquired long-term conditions that are attributed to impairment of the brain 
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and/or neuromuscular system that create functional limitations, 
including difficulties with movement, cognition, hearing and 
vision, communication, emotion, and behavior” (1). Historically, 
this population has been variably referred to as children with 
neurodevelopmental disorders or with neurodevelopmental dis-
abilities, with these two terms often used interchangeably (2–6). 
Although changes in usage may arise following adoption of the 
term “neurodevelopmental disorders” as a specific category in 
the Diagnostic and Statistical Manual of Mental Disorders, 5th 
Edition (DSM 5) (7), in this essay, we argue that conceptual and 
empirical advances have made it more important than ever to 
differentiate the terms “disability” and “disorder.”
The long-standing, yet anomalous, practice of using two 
terms interchangeably to refer to the same population of children 
remains worthy of critical exploration regarding what it may 
reveal about the perceptions and attitudes that underlie both 
health-care practice and policy. One explanation is that disorders 
and disabilities are two terms that mean the same thing, and so 
are thought to be interchangeable (Explanation 1). Another is that 
they mean and connote different things, but widespread lack of 
awareness of the differences (as discussed in this essay) allows 
them to be conflated in general use (Explanation 2). The third 
possibility is that the people referred to, and specifically children 
as the focus of this paper, have (or are assumed to have) both 
disorders and disabilities, so either term is thought to be accept-
able. In this scenario, it is possible that use of one or the other 
term may be more appropriate, but guidelines for this are lacking 
(Explanation 3).
This paper explores these possible explanations. It proposes 
that discrete perspectives about disease and disability underlie 
approaches to everyday clinical work, policy-making, and 
research with populations affected by chronic conditions, includ-
ing children with neurodisability, but the distinctions between 
them may seem subtle and not worthy of critical scrutiny. We 
propose that these perspectives can and should be clearly identi-
fied and then explicitly applied to inform clinical practice and 
policy planning. The rationale for this proposed “parsing” of the 
language is addressed through four themes.
First, we elaborate on the argument concerning the distinct-
ness of the concepts of disease and disability by describing their 
relationship within the World Health Organization’s (WHO) 
International Classification of Functioning, Disability and Health 
(ICF) (8), widely considered to be the contemporary reference 
conceptual framework for disability. We then outline the main 
characteristics and epistemic underpinnings of disease and 
disability perspectives in health care, as we see them. Second, 
we review the “goodness of fit” of each perspective in relation 
to childhood neurodisability, with reference to clinical realities 
of the field, emerging evidence, and trends in advocacy. Our 
third theme is a review of each perspective’s current use and 
place in relation to childhood neurodisability, along with some 
factors that contribute to the status quo. Finally, we conclude 
with suggestions for moving forward in order to achieve a more 
appropriate balance in deployment of each perspective; this 
includes practical strategies to promote explicit awareness, and 
appropriate adoption/implementation of disease and disability 
perspectives in child health and neurodisability.
At the outset, we need to point out that the perspectives on 
disease and disability discussed in this paper are not identical 
to the medical and social models of disability that have been 
thoroughly described elsewhere (9–11), although there is overlap 
with these approaches. The latter represent conceptual views or 
models of what disability is. The present paper takes ICF to be 
the contemporary working framework to conceptualize disability 
within health, and aims to demonstrate and elaborate on how 
distinct disease and disability perspectives subtly but importantly 
shape thinking and action on the part of health-care providers, 
and notably, physicians, as well as researchers, educators, and 
policy makers. Through a process that highlights and makes these 
perspectives explicit, it is hoped that we may actually update and 
go beyond previous positions on biomedical vs. biopsychosocial 
models in health care (12), thereby facilitating improvement in 
service delivery, policy making, and outcomes for persons with 
chronic health conditions associated with disability. As men-
tioned, our particularly focus is on children with neurodisability 
and their families.
THeMe 1: DiSeASe AND DiSABiLiTY 
CONCePTS AND PeRSPeCTiveS
Disease and Disability Terms and 
Concepts in the era of iCF
Since its release in 2001, ICF has become the predominant 
conceptual framework for the human experience of health and 
disability (13, 14). While certain aspects of the ICF (such as the 
actual classification – the “C” in ICF) remain subject to critical 
commentary (13), the framework is increasingly used to organ-
ize scholarly as well as clinical activities. Key features of ICF that 
significantly advance the conceptualization of disability within 
health are that (i) disability is framed in functional terms, as the 
converse of healthy functioning; (ii) functioning is understood 
to manifest at the level of body, person, or person-in-society, 
operationalized, respectively, as intactness (or impairment) of 
“body structures or physiological functioning”; ability to carry 
out daily activities (“activities” or limitation thereof); and “par-
ticipation” (or restrictions) in meaningful activities with other 
people; (iii) disability is not “in the person” but results from 
interactions between health conditions and contextual (usually 
environmental) factors; and (iv) functioning, health conditions 
(diagnosed diseases and disorders), and contextual factors (both 
environmental and personal) are each distinct and intercon-
nected components of health.
Insofar as the ICF framework depicts diseases (or, more 
accurately, “health conditions”) and disability as distinct ele-
ments, the notion that disease and disability are the same and 
hence interchangeable (Explanation 1) is not viable in the ICF era. 
Illustrating this notion are the separate WHO international clas-
sification systems that exist for health conditions (diseases and 
disorders) and disability, namely, the International Classification 
of Diseases (ICD-10) and ICF, respectively. While intended by 
WHO to be taken as complementary (8), the distinctness and 
complementarity of diseases and disability have not always been 
so clearly set out. In fact, earlier attempts at classification of 
TABLe 1 | Disease and disability perspectives: components and characteristics.
Disease perspective Disability perspective
Focus, terminology, and 
taxonomies
Health conditions: diseases and disorders as seen 
through a biomedical lens
Disability (or disabilities): function and functioning as seen through a social 
impact lens
“Diagnosis” arrived at by “ruling out” alternate 
explanations for the problem
“Formulation” arrived at by “ruling in” relevant positive and negative 
elements of a person’s situation
Classified and cataloged in ICD-10 and DSM 5 Components and classification covered in ICF
Underlying conceptual basis 
and intervention paradigm
Biomedical (paradigm) diagnostics and therapeutics 
(“diagnose-and-treat”); treatment based on 
understanding of underlying biological derangements 
(pathophysiology). Hence, a strong reliance on 
biomedical science as the language of disease
Biopsychosocial model, which takes account of various factors within 
the person and their environment, in addition to biological derangements. 
Hence, the language of the social model of “person-in-environment”
Aims of intervention Treatment aims to halt, and where possible reverse, 
underlying pathological processes; ultimately, if possible, 
to cure or at least control the condition
Rehabilitative interventions aim to mitigate effects of disease or disorder; 
to improve/optimize functioning though focus on the individual’s skills and 
environmental supports and adaptations; and to enable people to try to 
achieve their own life goals in their own ways
Proposed epistemic 
underpinning
Nomothetic Idiographic
Aims for knowledge that is broadly applicable through 
study of things/phenomena as categories (see text)
Aims for knowledge that helps to understand phenomena through detailed 
description of individual experience (see text)
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disability (15) tended to see disability as merely a “by-product” 
of diseases or disorders, reflecting perhaps the pre-eminence 
of a biomedically based diagnostic–therapeutic model in the 
twentieth century. The distinctness and complementarity of cur-
rent ideas can be highlighted, and thereby better actualized, by 
dissecting out and making explicit the perspectives on disease 
and disability in health care and health services.
Disease and Disability “Perspectives” – 
Characteristics and Underpinnings
The key components and characteristics of what this paper 
identifies as disease and disability perspectives are summarized 
in Table 1, along with a proposed designation of the epistemic 
underpinnings (or theories of knowledge) of each perspective.
Disease and disability perspectives clearly differ in their 
chief characteristics and appear to be underpinned by different 
epistemic foundations, which we believe to be represented best 
by the “nomothetic” and “idiographic” approaches to knowl-
edge described by Austrian philosopher Wilhelm Windelband 
(1848–1915) (16). The nomothetic approach to knowledge refers 
to and emphasizes how knowledge can be generalized, extended 
to categories of things or phenomena, thus framing the knowl-
edge generated in this way in terms of universal principles. This 
approach is best suited to the study of objective phenomena and 
hence finds most appropriate application in the natural sciences. 
Idiographic knowledge, on the other hand, is primarily focused on 
the individual case (hence “idio-”), whether a particular person 
or phenomenon. The emphasis is on the meaning of contingent, 
unique, and subjective phenomena relevant to the individual. 
This approach is therefore most closely identified with (and 
appropriate for) the humanities (16, 17).
The nomothetic approach to knowledge as described by 
Windelband seems to form a natural epistemic base for the 
disease perspective, with its focus on diseases as phenomena in 
the natural world, organized into categories in which each has 
its own etiology, pathophysiology, natural history, classification, 
and epidemiology. The disability perspective, on the other hand, 
is primarily concerned with variations in functioning among 
individuals, and the contingencies that underlie these variations. 
The aim is to describe how a person is functioning – at the levels 
of body, person, and person-in-society – and to account for an 
array of contributing factors (biological, personal, and envi-
ronmental), the effects of which may be mitigated to optimize 
that person’s functioning. The disability perspective therefore fits 
closely with idiographic description and knowledge. And though 
an idiographic approach has been identified with the humanities, 
we can envision such as approach as one that aims for synergy 
between scientific and humanistic currents in health care (18–20). 
In the current era, some of the most effective and moving medical 
writing has been crafted by master clinicians with an eye and ear 
for the human dilemmas that make each expression of a “disease” 
unique and compelling (21–24).
THeMe 2: DiSeASe AND DiSABiLiTY 
PeRSPeCTiveS: THeiR GOODNeSS OF 
FiT wiTHiN CHiLDHOOD 
NeURODiSABiLiTY
Goodness of Fit in Relation to Clinical 
Realities of Childhood Neurodisability
A biomedical diagnostic–therapeutic orientation to health care is 
integral to current versions of the disease perspective; its nomo-
thetic basis is evident in the categorical way in which diagnoses 
and treatments are approached. Identification of a diagnosis leads 
directly to planning and implementation of “treatments” and 
“interventions” that wherever possible are meant to be specific 
for that category of disease or risk factor. This approach has been 
remarkably effective in management of many health conditions in 
clinical care (25), especially acute conditions, among which strep-
tococcal pharyngitis may be considered prototypic. A patient’s 
symptoms (fever and sore throat) lead to diagnostic-specific 
4Miller and Rosenbaum Disease and Disability Perspectives in Childhood Neurodisability
Frontiers in Public Health | www.frontiersin.org October 2016 | Volume 4 | Article 226
identification of a condition (“Strep throat”) whose etiology 
and pathophysiology are well understood, allowing for targeted 
treatment (antibiotic with appropriate sensitivity to this strain of 
Strep) to halt and reverse the disease process and its effects in a 
fairly specific way. This approach has also been instrumental in 
public health control of diseases such as infections, nutritional 
deficiencies, and certain cancers, once the underlying causal 
pathways and biological derangements have been identified and 
found to be remediable or reversible (26, 27).
Childhood neurodisability, however, has two key characteris-
tics that substantially reduce the “goodness of fit” of this approach. 
First, despite the plethora of labels in this field, the diagnoses 
among children with neurodisability convey limited knowledge 
of underlying biological processes toward which specific treat-
ments might be directed with the intent of reversal or biomedical 
cure. Second, the mainstays of “treatment” are a range of (re)
habilitative (development-promoting) and supportive services 
aimed at the person (and their family) and the environment, in 
order to promote adaptation and optimize functioning in ways 
that reflect that person’s interests and capacities. In the following 
paragraphs, we expand on what is distinctive about diagnoses and 
treatments/interventions in childhood neurodisability.
“Diagnoses” of children with neurodisability can be sorted into 
two main kinds: developmental, based primarily on describing 
functional characteristics within classical domains of child devel-
opment, and including an alphabet soup of labels such as ASD, 
ADHD, ID, or DCD (representing autism spectrum disorder, 
attention-deficit/hyperactivity disorder, intellectual disability, and 
developmental coordination disorder, respectively); or medical, 
named on the basis of a primary underlying etiology – examples 
include Down syndrome, Fragile X, and fetal alcohol syndrome. 
The first kind of diagnoses have much in common, and indeed 
overlap, with mental health/psychiatric conditions, such as anxi-
ety and depression. All of these are phenotypically and phenom-
enologically descriptive, “polythetic-categorical” entities (28). 
They identify constellations of features consisting of observable 
behaviors and/or subjectively reported feelings or phenomena. 
To be included in a developmental diagnostic category (disorder 
present – yes/no), a person must have a minimum number of 
defining characteristics out of a larger set, in which no individual 
feature is necessary or sufficient on its own. These diagnostic 
categories are organized in taxonomic systems such as DSM (7), 
but DSM was never intended by its authors to be informative as 
to etiology (28–30). Diagnoses of the medical–etiological kind, 
on the other hand, usually require presence of specific biomark-
ers and are often strongly informative as to etiology. However, 
they convey limited information about a diagnosed individual’s 
specific functional phenotype or the impact of that diagnosis on 
that person’s life. Most relevant to this discussion is that neither 
kind of diagnosis provides information that can be readily slotted 
into a biomedical diagnostic–therapeutic model. Advances in 
neuroscience have helped to identify broad trends and tendencies 
in brain structure and function among persons in diagnostic cat-
egories spanning the neurodevelopmental–mental health divide, 
such as ASD (31, 32), but this information is limited in its ability 
to predict malfunctioning at the biological or physiological level 
within individual children (33, 34). In addition, because many of 
these diagnoses identify conditions that are genetic or teratogenic 
in origin, given the current state of therapeutic technologies, a 
medical–etiological diagnosis often does not provide a guide to 
interventions aimed at halting or reversing specific pathological 
processes. An important exception is the small group of inborn 
errors of metabolism that may be amenable to specific interven-
tion capable of halting and possibly improving disability (35). In 
the future, technological advances in “precision medicine” may 
allow knowledge of specific genetic etiology to be used to tailor 
biological treatment approaches for certain conditions, as is hap-
pening already in epilepsy (36). At present, however, knowing a 
diagnostic category rarely leads to specific therapy along the lines 
of the streptococcal pharyngitis example used earlier.
Another feature of neurodevelopmental disorder/disability 
diagnostic categories, whether developmental–functional or 
medical–etiological, is the stunning diversity and heterogeneity in 
clinical characteristics among children who fall within a category 
and the clinical and functional overlaps between categories. This 
is in part a function of categorical-polythetic diagnoses in which 
symptom profiles can vary markedly across individuals who all 
meet criteria for membership of a diagnostic category (29, 34, 37, 
38). This reality is reflected, for example, in increasing use of the 
term “spectrum disorders” to describe neurodevelopmental con-
ditions; references to “the autisms” as a more authentic term than 
the more traditional “disease”-based designations (39); and the 
emphasis in contemporary definitions of cerebral palsy (CP) as 
a “heterogeneous group of disorders” (40). Adding to this source 
of diversity and heterogeneity among diagnosed children are the 
twin phenomena of “comorbidity” and “functional complexity” 
now recognized as another hallmark feature of children with 
neurodisability (41–46).
The consequence of all of these considerations is that, in the 
context of childhood neurodisability, a diagnosis may tell us 
relatively little about the individual person and their abilities, 
let alone their needs. As a result, in contrast to the role that diag-
nosis plays in the biomedical diagnosis–therapeutic paradigm 
that currently characterizes the disease perspective, a diagnosis 
of ASD, ID, or 22q11 deletion syndrome cannot be assumed to 
lead naturally to the design of interventions that are specific to, 
appropriate for, or capable of meeting the needs of the diagnosed 
child diagnosed, or his or her family. Indeed, commonly used 
phrases such as “treatment of ASD” may serve to perpetuate a 
misconception, even a myth, in child health. In the real world, 
we usually have to help families “manage” a child with a diagnosis 
of ASD, or support their different development. That child may 
differ substantially from another child diagnosed with ASD in 
terms of primary symptomatology and in the presence of absence 
of additional diagnoses, or perhaps just features, of ADHD or 
ID. Furthermore, the child’s family may experience considerable 
psychosocial stress, which, if not addressed, will make it difficult 
to create an environment supportive of positive development 
change.
This is not to say that biomedical diagnosis is unimportant 
within childhood neurodisability. Determining that a child has 
ASD, ADHD, or 22q deletion syndrome can be extremely impor-
tant for a host of needs/purposes ranging from direct treatment 
in cases of inborn errors of metabolism to prevention through 
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genetic counseling and to facilitating communication with par-
ents and among professionals and affected persons. Diagnoses 
are also critical for administrative and epidemiological purposes 
and for addressing the important human need to “put a name 
on it” (47). Naming a condition in turn allows people to identify 
themselves and deal with their predicament adaptively through 
learning about it and connecting with others. However, it cannot 
and should not be assumed that a descriptive diagnosis of ASD or 
ADHD, or even a situation in which a specific etiology is known 
or suspected for a functionally defined condition (such as ID due 
to Down syndrome, or which occurs as a complication of neo-
natal adversity such as extreme prematurity), leads naturally to 
the design of interventions that are specific to, appropriate for, or 
capable of meeting the needs of an individual person diagnosed 
with ASD, ID, or 22q11 deletion syndrome.
Turning to the nature of treatments and interventions for 
children with neurodisability, these mainly reflect the habilitative 
(developmental) focus that is integral to the functional/disability 
perspective, coexisting with treatments that target known and 
understood pathophysiological (biomedical) mechanisms. One 
major class of interventions includes educational and behavioral 
strategies, and another comprises medications, surgeries, and 
specialized equipment and surgeries. But whatever the class, it 
is rare that treatments and interventions target an underlying 
etiopathological (biological) process that is specific for diagnosed 
disorders, such as ASD, ADHD, and DCD, language disorders, CP, 
Fragile X syndrome, or fetal alcohol spectrum disorder (FASD). 
Psychologically based interventions that aim at teaching skills or 
changing behavior are widely used in childhood neurodisability, 
especially for the less visible, less physical challenges. Within 
these broad categories are more specific therapy types, such as 
applied behavioral analysis (ABA) under the category of behav-
ioral interventions, the Orton–Gillingham approach under edu-
cational interventions, and cognitive behavioral therapy (CBT) 
under psychological interventions. All of these are supported by 
evidence of effectiveness, but none of which is truly specific to 
any one disorder. ABA is most-widely known for its effectiveness 
when used with children diagnosed with ASD (48), but ABA, 
and the associated early intensive behavioral intervention (EIBI) 
approach, has been found to be effective in other situations too 
(49). More broadly, psychosocial and family-based approaches 
are known to be effective in management of many childhood dis-
orders (50–52). In terms of educational interventions, strategies 
such as providing a student with visual supports is recommended 
and helpful for any child whose learning is affected by auditory 
or language weaknesses, regardless of any particular medical 
diagnosis. Mental health conditions occur far more frequently 
among children and youth with ID and neurodevelopmental 
conditions than among typically developing children (53), and 
CBT has been found to be across a wide range of mental health 
disorders in children and youth (54). In other words, the best of 
these many interventions are not condition-specific; rather, they 
address symptoms and behaviors.
Medications, often seen as the prototypical “biological” inter-
vention, rarely have the kind of specificity that is such a hallmark 
of the biomedical diagnostic–therapeutic strategy (55) typified 
by antibiotics for streptococcal pharyngitis or insulin for type I 
diabetes, when used in the course of management of children 
with neurodisability. Stimulants such as methylphenidate, a com-
monly used treatment for ADHD, may also be efficacious in neu-
rological dysfunction post-traumatic brain injury (56); baclofen, 
most closely associated with CP, may be useful for management 
of spasticity regardless of cause (57), while clonidine, often used 
adjunctively in ADHD, may also be useful for spasticity follow-
ing brain injury (58). Similarly, psychopharmacological agents 
including the so-called antipsychotic drugs are used in manage-
ment of children with various neurodevelopmental conditions to 
help control aggressive behavior, agitation, or irritability (59, 60), 
just as the SSRI “antidepressants” are useful in management of 
anxiety and/or compulsive and repetitive symptomatology (61) 
in the absence of psychosis or depression. At the present time, 
treatments that successfully affect CNS functioning, whether 
biologically active or experience-based, do so in ways that cannot 
always be predicted based on a specified diagnosis. Conversely, 
when prescribing an SSRI on the basis of experiential evidence of 
effectiveness, the prescriber does not know whether serotonin is 
lacking in the specific patient’s brain pathways.
More broadly, these comments fit with a rising tide of evidence 
for the benefit of “lifestyle” interventions for various develop-
mental, behavioral, and mental health conditions. For example, 
exercise and physical activity have been shown to be effective as 
part of a set of interventions for ADHD (62) but not limited to 
ADHD; efficacy has been demonstrated also for depression (63) 
and will likely be shown for conditions too. So while it is fair to 
say that exercise or physical activity has a therapeutic effect in 
ADHD or depression, a view that better fits all the available evi-
dence is that exercise and activity appear to have salutary effects 
on brain functioning in general and perhaps even more clearly 
in certain situations of disrupted or dysregulated brain function. 
We can conclude by saying that evidence for the effectiveness of 
many interventions for children with childhood neurodisability 
and many mental health conditions is usually derived from 
condition-based studies and so is presented as a treatment for 
condition A or B; in reality, however, the interventions themselves 
are far from condition-specific.
Goodness of Fit in Relation to emerging 
evidence and Contemporary Advocacy in 
Childhood Neurodisability
A body of empirical evidence is emerging to support the notion 
that, in relation to neurodisability in children and youth, a disease 
perspective that places a person’s diagnosis at the center is less 
relevant (or appropriate) for planning interventions, services, and 
supports than a disability perspective in which individual func-
tional characteristics are carefully considered as a starting point 
for “management.” Recent evidence builds on seminal findings of 
Stein and Jessop that for children with chronic health conditions, 
diagnostic category may contribute little to our understanding 
of the impact, needs, or psychosocial correlates of the condition 
in that individual (64). Subsequent work includes the illustration 
that, in a large population of children and youth with CP, neither 
the topography nor the type of motor impairment of the CP 
predicted their functional abilities (65), as described with a valid 
6Miller and Rosenbaum Disease and Disability Perspectives in Childhood Neurodisability
Frontiers in Public Health | www.frontiersin.org October 2016 | Volume 4 | Article 226
and reliable functional classification system (66). More recent 
demonstrations of this idea include studies that contrast the 
role of functional characteristics against established diagnosis in 
predicting need and use of supports and services, and conclude a 
centrality/primacy for functional characteristics (67–71). Finally, 
evidence from clinical- and population-based studies shows that 
child functional characteristics are more informative than child 
diagnosis status in explaining various child and family health and 
health-related outcomes among children with ASD and other 
NDD (72, 73).
Account also needs to be taken of contemporary stakeholder 
advocacy movements that strongly emphasize – when ascertain-
ing need for services and supports among persons with impair-
ments – the importance of adopting a functional approach that 
fits with our notion of a disability perspective. This is perhaps 
most clearly articulated in the approach advocated by American 
Association on Intellectual and Developmental Disabilities 
(AAIDD), using tools, such as the Supports Intensity Scale (74, 
75), that clearly are idiographically informed. Though more adult 
oriented, this approach has increasing relevance and is being 
investigated psychometrically among children and youth with 
disabilities (76).
THeMe 3: DiSeASe AND DiSABiLiTY 
PeRSPeCTiveS: CURReNT STATUS 
wiTHiN CHiLDHOOD NeURODiSABiLiTY
Theme 2 demonstrated that basic clinical realities of childhood 
disability, along with an emerging evidence base and increasing 
advocacy efforts, converge to make the traditional biomedical 
diagnostic–therapeutic approach, which is so central to the 
“disease” perspective, less appropriate for the context of child-
hood neurodisability than an ideographically informed disability 
perspective. In this section, we briefly examine the current status 
of health-care practices, policy making, and research in relation 
to that conclusion and review key factors that we consider to 
contribute to maintaining the status quo.
Conflation of disease and disability perspectives, and the 
imbalance between them, continues to be prevalent in health care 
and services planning. Conflation is most obvious in commonly 
used terminology. Beyond the example of the interchangeable use 
of neurodevelopmental disorders and disabilities that served as 
an important case-in-point and gateway into this paper, it is com-
monplace to hear that children with autism or Down syndrome 
“have – or even suffer from – a disability.” According to ICF, how-
ever, autism and Down syndrome are “health conditions” that 
the child “has,” while disability (or disabilities) is more precisely 
a state a person experiences and which manifests as impairment 
in aspects of body structure, or function, or in activity limitations 
or participation restrictions. For example, the child with Down 
syndrome may experience cognitive impairment, and the child 
with ASD may have social and/or adaptive impairment. But 
this is different from the implication that DS and ASD are, in 
themselves, disabilities. Conflation in common usage reflects, 
but also perpetuates, lack of precision and distinctness among 
these conceptually different perspectives. The fact that some 
terms actually straddle the disorder–disability divide further 
obscures these nuances. For example, “intellectual disability,” 
which primarily describes challenges in the functional areas of 
cognition and adaptive skills, and so is perhaps more accurately 
termed cognitive–adaptive (or intellectual) impairment (77), is 
itself codable as a “health condition” in DSM-5 under the hybrid 
rubric of ID (intellectual developmental disorder) (7). To go back 
to the explanations offered earlier in this paper, conflation maps 
on to Explanation 2: there may be some awareness of a difference 
between disease and disability perspectives, but sensitivity to the 
difference outlined in ICF, at least in terms of the language used, 
is lacking. The effect of this conflation is to reinforce, powerfully 
but insidiously, the primacy of disease perspectives (78), and 
to obscure the relevance of disability perspectives with their 
functional focus and social and implications for management 
and adaptation.
Imbalance between disease and disability perspectives is also 
seen in situations where a child’s diagnostic status may be used 
as the main or only determinant in planning for and regulating 
access to “ancillary and enabling” services and supports (79), with 
scant attention to the individual child and family’s functional 
characteristics and needs. Examples of this are found across 
jurisdictions and in relation to rehabilitative, supportive, and spe-
cial educational services, such as British Columbia’s specialized 
funding programs for children with special needs, which include 
two specific conditions, ASD and FASD (80); diagnosis-based 
eligibility criteria for early intervention services in Australia (81); 
and the targeting of specific neurodevelopmental diagnoses in 
Swedish legislation that regulates access to services (82). This 
situation is regrettable but also ironic in light of the increasing 
emphasis on both patient-centered care (83). Further examples 
from outside the health-care realm are the use of medical and 
other kinds of categories in classifications that determine chil-
dren’s eligibility for special educational supports (84, 85). These 
“other categories” are often referred to as disability categories, but 
as the preceding discussion will have made clear, they are more 
accurately framed as impairment categories.
Imbalance is also seen in clinical situations, when physicians 
may devote almost all of their energy toward attempts to identify 
a medical etiology for a child’s difficulties, and very little toward 
a more holistic formulation of functional strengths, limitations, 
and child and family needs. Sometimes, this professional activity 
extends to seeking and applying politically “useful” diagnoses to 
enable families to access services apparently reserved for people 
with that specific diagnosis (86); further consideration of this 
vexing situation goes beyond the scope of this paper, however.
In parallel, we see similar imbalance in the research field, 
where much of the funding for neurodevelopmental disorders/
disabilities goes to selected conditions such as ASD, with much 
of that research directed toward elucidating the underlying 
neurobiology of the condition (34, 38) and therefore expressing 
a disease (or disorder)-based perspective. It is possible that as 
precise mechanisms become elucidated, and if these mechanisms 
prove to be amenable to specific treatments, management of 
children with neurodisability will come to comprise a larger 
component of biological treatment aimed at reversing specific 
underlying pathological processes. However, we are reminded 
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that an exclusive focus on the biomedical nature of a neurodevel-
opmental condition, such as ASD, has not solved the daily living 
challenges of affected persons (38). Indeed, short of completely 
eradicating the underlying chronic condition, this approach is not 
likely to do so without individualizing the broader “management” 
of the conditions, in common with other chronic “medical” con-
ditions such as diabetes. Even when the focus of research is not 
on underlying biological or biomedical processes, but rather on 
effects and correlates of developmental and mental health condi-
tions, such as impact on child and family which have been shown 
to have important commonalities across conditions (64), research 
outputs still tend to reflect the disease or condition-specific silos 
from which they arise (87, 88).
A number of factors underlie and perpetuate the conflation 
and imbalance which characterize the status quo, of which we 
consider three briefly here. The first is simply a reflection of the 
relatively recent arrival of ICF into health care with its expanded 
range of ideas. The biomedical diagnostic–therapeutic approach 
has become established over a century and a half as the dominant 
paradigm in medical practice, education, and training (89), 
whereas the ICF framework was unveiled only 15  years ago. 
Traditional models of medical education may continue to empha-
size a biomedical diagnose-and-treat approach, and the resources 
to formally support learning about disability and rehabilitation 
often remains lacking (90). Innovative ideas and concepts tend 
to diffuse out, be debated, and taken up slowly into practice and 
policy, especially when the current state of health care, education, 
and policy reflects a culture that is oriented toward, and perpetu-
ates, a nomothetic disease perspective over an ideographic dis-
ability perspective.
This leads into the second factor, which is the existence of 
structural constraints in publicly funded service systems. In 
Canada, for example, the national health insurance program, 
known as Medicare (Canada), is designed to fund medical services 
and treatments, primarily physician or hospital-based services 
and interventions such as medication and surgery. This federal 
legislation renders as out of scope the “ancillary and enabling” 
services needed by persons with disability (79). In Canada, this 
gap is filled by provincial jurisdictions in a variable and piecemeal 
way across the country. The legislative-structural constraints 
described for Canada likely have analogies in other parts of the 
world. Their existence speaks to the very definition of health 
that law makers and societies use in formulating policies. When 
health policy remains narrowly defined, it will be less relevant 
to children with neurodisability and to adults and children who 
live with chronic conditions associated with disability. In the final 
theme of this paper, we propose thinking about “health and social 
policy” when it comes to persons living with disability.
Finally, there is the contribution made by administrative 
factors. Identifying health problems using diagnostic codes is 
a relatively simple and convenient way to summarize, capture, 
and store clinical information as required for administrative pur-
poses, such as utilization and billing for medical services, quality 
improvement, and epidemiological studies. One criticism that has 
been leveled at the disability perspective, and ICF in particular, is 
that it does not come with an easily implementable way of dealing 
with administrative needs in terms of convenience, efficiency, and 
succinctness (13). On the other hand, there has been increasing 
interest in development of functional classification measures with 
potential to fill this gap; we return to the topic of data collection 
and ways to address the other factors outlined here that maintain 
the status quo, under Theme 4.
Although in this section we have focused on conflation and 
imbalance as characterizing the status quo, it is not infrequent 
to find broader and more “progressive” deployment of disease 
and disability perspectives in policy, delivery, and education in 
health care. One example is evidence of increasing uptake of ICF 
domains in more recent population-based disability surveys, 
as reported from Ireland (91). In many jurisdictions, too, a 
“blended” approach exists for determining eligibility for services 
and supports for children with neurodisability and their families, 
resulting in a mix of policy approaches from diagnosis-specific to 
those emphasizing functional characteristics. Foundational pieces 
of legislation in the United States illustrate this. The Individuals 
with Disabilities Education Act (IDEA) adopts a largely categori-
cal approach to children’s service eligibility, except for children 
under 3 years of age who are eligible by virtue of having, or being 
at risk for, developmental delay which is not further specified. 
Alongside this blend of approaches in IDEA is the Americans 
with Disabilities Act (ADA), in which disabilities are broadly (and 
non-categorically defined) as significant physical, intellectual, 
emotional, or health limitations that interfere with life activities 
(Turnbull, personal communication). In Canada, a recent review 
of criteria for an array of (re)habilitative and special educational 
services and supports for children across the country found that 
early intervention services are generally functionally based, while 
access to behavioral interventions are largely diagnosis-based, 
certainly for preschool age, but also for school-aged children. 
ASD and, in some provinces of Canada, FASD, are the main 
diagnoses that “open the door” (92). For school-aged children, it 
is most common to find a combination of diagnosis and function-
based approaches used such that diagnostic categories are used 
to confer funding for supports and services to school districts, 
with these supports then delivered to individual students based 
on their functional needs (92).
THeMe 4: MOviNG FORwARD:  
A PROGReSSive AGeNDA FOR 
DePLOYiNG DiSeASe AND DiSABiLiTY 
PeRSPeCTiveS iN CHiLD HeALTH AND 
CHiLDHOOD NeURODiSABiLiTY
Can we Articulate a Clearer Balance 
between Disease and Disability 
Perspectives?
Before we embark on recommendations to shift the status quo 
on perspectives and approaches to persons with chronic health 
conditions associated with disability, we return to a point made at 
the beginning of this paper. Explanation 3 for the interchangeable 
use of the terms neurodevelopmental disorders and neurodevel-
opmental disabilities was that both terms may (at times) apply, 
but it is not clear when to use one and when to use the other. 
8Miller and Rosenbaum Disease and Disability Perspectives in Childhood Neurodisability
Frontiers in Public Health | www.frontiersin.org October 2016 | Volume 4 | Article 226
This explanation fits with the way the ICF framework depicts 
health conditions coexisting and dynamically interacting with 
functional aspects of health (or disability), and with contextual 
factors, even though the presence and fact of a chronic health 
condition does not necessarily mean a person experiences “dis-
ability.” Throughout this paper, we have argued for a greater 
emphasis on a “disability” perspective, in both its functional and 
contextual dimensions, assessing the day-to-day implications of 
a health condition for child and family. This includes aspects of 
health and social policy relevant to regulating access to services 
and supports. While this next point is perhaps obvious, we reit-
erate here the importance of a disease perspective in (i) clinical 
situations where, in the diagnostic phase, the aim is to identify 
an underlying medical diagnosis, with potential genetic, epide-
miologic, and prognostic implications and (ii) in research efforts 
that aim to understand the biological determinants of a patient’s 
predicament. Having a diagnosis can have important implica-
tions for treatment and prevention, as well as construction of 
social identity and psychological “closure” (47), as has been noted 
earlier, while knowledge of biological mechanisms advances the 
possibilities of prevention and cure.
Practical Steps/Strategies to Promote 
explicit Awareness and Appropriate 
implementation of Disease and Disability 
Perspectives in Child Health and 
Neurodisability
Shifting the status quo on perspectives and approaches to per-
sons with chronic health conditions associated with disability is 
an important endeavor. It emerges as a natural consequence of 
all that we have argued thus far about imbalance and neglect of 
the disability perspective in current practice, policy, education, 
and research. It is made even more compelling by an increasing 
body of evidence that demonstrates how, for children and adults 
affected by chronic health conditions, the presence of disability 
demarcates differences in impact and needs in a very robust way 
(93–96). The task ahead is to disentangle conflation, to recognize 
the complementarity of the disease and disability perspectives 
in the context of childhood neurodisability (as well as child 
health, and human health, more generally), and to see how each 
contributes to a deeper understanding of both individuals with 
impairments and to the field in which we work. We have argued 
that the first step in this long journey is to bring attention to, and 
highlight the notion of disease and disability perspectives, and 
how they underlie and shape much of what we do in the clinic, the 
laboratory, and in policy making, even if under-acknowledged 
(when not ignored completely). The next step is to ensure that 
both perspectives are actively considered at all times, with due 
regard to the question of when one perspective might claim 
primacy of place over the other.
The final part of this paper sets out practical steps – including 
actions/changes across a number of fronts – that we believe are 
necessary to achieve a new balance in activities that concern chil-
dren with neurodisability and their families. We organize these 
ideas, suggestions, and strategies under the headings of clinical 
practice; data collection approaches; tools to capture data on both 
health conditions (diagnosis) and function; health professional 
education; organization and prioritization of research funding 
and programing; and policy approaches.
Clinical Practice
Several changes can be instrumental in moving forward with 
recalibrating the weighting we give to disease and disability per-
spectives in clinical practice. At the level of basic organizational 
models of service, we recommend a shift toward non-categorically 
defined clinics for children with neurodisability, based on func-
tional rather than diagnostic considerations. In this scenario, a 
clinic’s mandate may be, for example, to assess and advise families 
of children with communication impairments, rather than chil-
dren with a particular diagnosis, such as ASD. Condition-specific 
clinics, such as those for autism or CP, are popular but tend to 
arise in response to the passions and pressures of interest groups, 
both professional and public/consumer. Though such clinics may 
be endowed with a significant body of expertise in relation to that 
condition, which may be necessary in some circumstances (e.g., 
a specialized multidisciplinary clinic dealing with children with 
spinal cord damage), for prevalent neurodevelopmental disor-
ders, the clinical realities of heterogeneity and complexity pointed 
out in Theme 2 make such a model less appropriate. They may 
also disenfranchise, and make “orphans” of, children who need 
clinical services to address phenotypically similar challenges but 
who do not appear to fit with the clinic’s condition-specific man-
date. On the other hand, “non-categorical clinics” for children 
with what we may call complex neurodevelopmental conditions 
would have a pool of the expertise needed to deal with the 
challenging behaviors, learning issues, and family impacts that 
occur in common across the full range of conditions. This would 
happen irrespective of the specific genetic or teratogenic etiology 
and would be open to children irrespective of these considera-
tions. Movement in this “non-categorical” direction is seen in the 
contemporary “complex care” movement, particularly strong in 
the United States and Canada, with a tremendous upsurge of 
interest in organizing clinical services based on a clinical popula-
tion defined by complex service needs rather than by a specific 
diagnosis, or the multiple diagnoses, that affected children may 
have (97). Part of making a non-categorical approach successful 
will be educating parents, professionals, program managers, and 
policy makers about its rationale and value, and the need to bal-
ance diagnostic with functional considerations without “taking 
away” a diagnosis for their child.
The next step is to ensure that, within clinics that assess chil-
dren with possible neurodisability, the diagnostic phase involves 
processes designed to make both a biomedical diagnosis (devel-
opmental and/or medical–etiological) and a clear functional 
assessment that describes and summarizes – essentially formu-
lates – the most relevant functional information. How we might 
move toward achieving this is covered below and will clearly 
involve implementation of the ICF concepts in clinical work, 
along with the consistent use of relevant functional assessment 
tools. As current examples of “work in progress” one of us (Peter 
Rosenbaum), in collaboration with PhD students, is presently 
working on developing and evaluating modules for parents of 
children with CP to introduce these concepts to them (98), and 
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also on developing an “F-words” hub, along with parents mem-
bers of the research team, to make ideas about the “F-words in 
childhood disability” (99) easily accessible and useable. Parents, 
of course, represent one force by which the system can be changed 
from the “bottom up.”
In its turn, the treatment/intervention phase must explicitly 
cover all aspects of intervention and supports, including medical 
or surgical treatments, specific therapies, equipment, and tech-
nologies, all designed to promote and optimize performance of 
daily activities and social participation, as well as measures to 
make the environment (family, school, neighborhood) as promo-
tive for these things as possible. Below we refer to the F-words 
ideas that discuss function, family, fun, friendships, fitness, and 
future – concepts that can inform all our work with children with 
impairments and their families. Sometimes families perceive 
that, at least in the context of specialized hospital services for 
children with chronic conditions associated with disability, the 
ancillary and enabling services are neglected in a way that is very 
problematic for the family (100).
Data Collection Approaches and Tools
Part of implementing a disability perspective more fully and 
explicitly into clinical care involves paying more attention to 
functional aspects of health. There are various ways to achieve 
this. First is the need to incorporate ICF-based fields routinely 
in every clinical assessment for children with neurodisability. 
We can also consider the creation of an ICF-based template with 
which to identify an individual’s issues, strengths, and needs. 
An example of this has been created by the second author and 
his colleagues, building a set of “F-words” (function, family, fit-
ness, fun, friends, and future) onto the ICF framework (99). The 
approach is strengths-based, family-friendly, comprehensive, and 
can be individualized by the person with the impairment, their 
family, and their clinical team. Such an approach has the benefit 
of reminding all the players to see these aspects of people’s lives 
and not simply the ICD-10 codes as a shortcut to the person.
Beyond the ICF, in the field of childhood disability, there are 
now several purpose-built valid and reliable functional classifica-
tion systems, many in use around the world, which provide per-
spectives complementary to the diagnostic terms. Tools, such as 
Gross Motor Function Classification System (GMFCS), Manual 
Ability Classification System (MACS), Communication Function 
Classification System (CFCS), and Autism Classification System 
of Functioning: Social Communication (ACSF:SC), capture 
functional information (“profiles”) in a practical, convenient, and 
psychometrically sound way that may make them more suitable 
for the task than ICF as it is currently formulated (certainly with 
respect to the limited capacity of the ICF to “classify” function-
ing). The goal of creating a profile of the current functioning for 
each child will involve agreeing on a set of measures we should use 
for every person with a neurodevelopmental disorder/disability, 
without assuming that a child with CP simply gets the GMFCS 
and a child with ASD gets the communication scale ACSF:SC. 
Functional profiles can and should include a focus on “can-do” 
areas and strengths, guided perhaps by the F-words model/tem-
plate (99). In this way, assessment will lead naturally to address 
the broad question of: What is “treatment” or “intervention” 
meant to accomplish? Whose goals are important? What will the 
child or youth be able to do – or do better – now than before? 
The questions asked will inform the choice of the tools to find 
answers. Other contemporary measurement tools designed to 
capture functional information, either in relation to ICF domains 
(101) or in terms of needed functional supports (74, 75), are pres-
ently available primarily for adults but are likely to prove useful 
as part of implementation of the disability perspective in child 
health with further validation in this population (76).
Ultimately, we believe that a matrix of diagnostic and func-
tional descriptions – based on disease and disability perspectives, 
and on the intended purposes of the data generated – will enable 
clinicians, researchers, administrators, and policy makers to 
recognize explicitly the interconnections between these ways of 
talking about the children and youth to whom we are all commit-
ted. They will then be able to use this cross-linked information 
for their many purposes without confusing one perspective with 
another.
Professional Education
As we noted regarding clinic work, there are also several kinds of 
changes that can be instrumental in moving forward in the area 
of education to recalibrate how disease and disability perspectives 
are aligned and weighted. The following recommendations apply 
in the broadest sense to education not only of trainees in the 
health professions but also of the public at large and to policy and 
decision makers. These recommendations are particularly salient 
in medical education, which remains largely in thrall to biomedi-
cal diagnostic–therapeutics (89, 102), and in recognition of the 
important role that physicians and other health professional 
leaders play in influencing practices, perceptions of health, and 
policies. At a fundamental level, and regardless of the biomedi-
cal condition, we encourage discourse in learning settings to be 
framed in the language of “people with health conditions,” with 
a move away from a more traditional focus on teaching about 
diseases. Our next recommendation is that educators disseminate 
the notion of disease and perspectives (at a conceptual level), as 
well as teach and discuss the non-categorical approach in child 
health, including its strengths and limitations. We recommend 
that educators promote a wide awareness and use of ICF frame-
work – at very least, in its conceptual side, e.g., teaching the ICF 
framework to health-care trainees (103). In a promising develop-
ment, at McMaster University in Canada, a biennial academic 
course on the ICF is now offered at the School of Rehabilitation 
Science, and ICF has been recently introduced to the Faculty of 
Health Science’s Program in Interprofessional Education (104). 
Finally, clinician-educators can serve as role models for an explicit 
embrace of disease and disability perspectives by organizing our 
own clinical work and research with this dual perspective always 
visible, and through a willingness to let go of disease-based silos.
Organization and Prioritization of Research Funding 
and Programing
A main strategy here is to create a better balance between 
research done in diagnosis-based silos and research based on 
non- categorical approaches. Successes and frustrations of the 
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non-categorical approach are discussed in a review of the 25-year 
history of the Research Consortium on Children with Chronic 
Conditions (105). Tangible progress in the direction of better 
balance can be seen in an increasing body of research, especially 
from the United States on “children with special health care 
needs” (106, 107), and the recent emergence of Complex Care 
as a focus of clinical and academic activities (97, 108). Research 
involving children with neurodevelopmental disorders/disabili-
ties, or “neurodisability,” as a non-categorical endeavor, remains 
limited however, with some notable recent exceptions (1, 43, 109). 
Most child health research continues to be funded and carried out 
at disease or condition level. We have argued that core “clinical 
realities” of childhood neurodisability, including clinical het-
erogeneity and comorbidity/complexity, detract from the validity 
and meaningfulness of work organized in this way. Even studies 
that may best be construed as advancing knowledge about chil-
dren with neurodisability broadly, in which findings really speak 
to the effects of children’s functional characteristics in relation 
to consequences and implications, are often reported in a way 
that emphasizes the significance of one condition over another, 
a situation we have discussed elsewhere (72). In this essay, we 
have referred to the strong evidence of the commonalities across 
biomedically distinct chronic conditions. While in no way calling 
for an end to biomedical research into these myriad conditions, 
we believe that there are important opportunities to aggregate 
parental and child experiences across these many conditions as 
a basis for increasing the numbers of people contributing to the 
research endeavors and for capitalizing on the application of the 
findings. These efforts will also serve to demonstrate to clinicians, 
families, service providers, and policy makers that the traditional 
balkanization of service and research activities is limiting and out 
of date with modern thinking and should be abandoned.
Policy Approaches
As has been noted elsewhere in this paper, in the area of policy 
making in chronic childhood conditions, we recommend replac-
ing policies regulating access to services and supports based on 
diagnostic category with a less categorical and more disability-
based perspective-oriented approach. Such an approach places 
functioning (at level of body, person, and person-in-society) and 
the person’s context as the central considerations. The first step 
toward this move will require conversations with policy and 
decision makers to explain the rationale based on the arguments 
made in this paper, including the notion of “disease and disability 
perspectives.” This is the responsibility of clinicians, educators, 
and leaders in health services research, who will also need the 
skills to anticipate “real world” political pressures that decision 
and policy makers confront from health condition-related activ-
ism. This process can align itself, when appropriate, with ongo-
ing lobbying/advocacy on the part of groups, such as American 
Association for Intellectual and Developmental Disabilities, for 
increasing use of needs-based assessments that look at functional 
limitations, such as SIS (74–76, 110), but also with due considera-
tion given to functional strengths, and not only within the child 
but also the family and, ultimately, the community.
CONCLUDiNG COMMeNTS
A confluence of factors spanning evolution in core concepts, 
shifting priorities, and innovations in measurement make this a 
moment of historic opportunity, in our view, for decisive progress 
in health care and services not only for children with chronic 
health conditions typically associated with disability but also for 
persons of all ages. We hope our framing of diseases and disability 
perspectives may contribute to ongoing and productive discus-
sion and progress.
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